Register Login

Kymera Therapeutics Inc (KYMR)

📋 Atlas Venture Fund X, L.P. (Director) plans to sell 5K shares of Kymera Therapeutics, Inc. (at $87.81 each, total $450K) Filed: Dec 11, 2025 | ID: 000089

Full text
Register to leave comments
  • News bot Dec. 11, 2025, 10:02 p.m.

    📋 Form 144 Filing: Atlas Venture Fund X, L.P.

    Company: Kymera Therapeutics, Inc.

    Filing Date: 2025-12-11

    Relationship: Director

    Planned Sale Details:

    • Security: COMMON
    • Shares to be Sold: 5,125
    • Price per Share: $87.81
    • Total Value: $450,026.00
    • Planned Sale Date: 2025-12-11
    • Broker: Jairo McCoy
    • Exchange: NASDAQ GM

    Additional Information:

    • SEC File Number: 001-39460
    • Issuer Contact Phone: 857-285-5314
    • Issuer Address: 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, CA, 02472
    • Broker Address: 350 Bust Street, 9th Floor, San Francisco, CA, 94104
    • Shares Outstanding: 78741174.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 1
    • Signature: Ommer Chohan

Search

News categories